BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment
Abstract Background In recent years, drug screening has been one of the most significant challenges in the field of personalized medicine, particularly in cancer treatment. However, several new platforms have been introduced to address this issue, providing reliable solutions for personalized drug v...
Main Authors: | Majid Mokhtari, Samane Khoshbakht, Mohammad Esmaeil Akbari, Sayyed Sajjad Moravveji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-023-01745-y |
Similar Items
-
Correction: BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment
by: Majid Mokhtari, et al.
Published: (2024-01-01) -
WASF3 overexpression affects the expression of circular RNA hsa-circ-0100153, which promotes breast cancer progression by sponging hsa-miR-31, hsa-miR-767-3p, and hsa-miR-935
by: Majid Mokhtari, et al.
Published: (2023-12-01) -
Repurposing Drugs in Small Animal Oncology
by: Antonio Giuliano, et al.
Published: (2022-12-01) -
Differential expression analysis in epithelial ovarian cancer using functional genomics and integrated bioinformatics approaches
by: Maryam Noei-Khesht Masjedi, et al.
Published: (2023-01-01) -
Repurposing of a human antibody-based microarray to explore conserved components of the signalome of the parasitic nematode Haemonchus contortus
by: Jack Adderley, et al.
Published: (2022-07-01)